Loading...

Jason Pomerantz, MD

TitleAssociate Professor
SchoolUCSF School of Medicine
DepartmentSurgery
Address513 Parnassus Ave
San Francisco CA 94143
Phone650-380-3509
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Albert EinsteinM.D.2000School of Medicine

    Collapse Research 
    Collapse Research Activities and Funding
    Mechanisms Underlying Plasticity of Gene Expression
    NIH/NIAMS F32AR051678Sep 1, 2004 - Aug 31, 2006
    Role: Principal Investigator
    Mechanisms Underlying Plasticity of Gene Expression
    NIH/NIAMS F32AR051678Sep 1, 2004 - Aug 31, 2006
    Role: Principal Investigator
    Mechanisms Underlying Plasticity of Gene Expression
    NIH/NIAMS F32AR051678Sep 1, 2004 - Aug 31, 2006
    Role: Principal Investigator
    Mechanisms Underlying Plasticity of Gene Expression
    NIH/NIAMS F32AR051678Sep 1, 2004 - Aug 31, 2006
    Role: Principal Investigator
    Mechanisms Underlying Plasticity of Gene Expression
    NIH/NIAMS F32AR051678Sep 1, 2004 - Aug 31, 2006
    Role: Principal Investigator
    Mechanisms Underlying Plasticity of Gene Expression
    NIH/NIAMS F32AR051678Sep 1, 2004 - Aug 31, 2006
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Niethamer TK, Larson AR, O'Neill AK, Bershteyn M, Hsiao EC, Klein OD, Pomerantz J, Bush JO. EPHRIN-B1 Mosaicism Drives Cell Segregation in Craniofrontonasal Syndrome hiPSC-Derived Neuroepithelial Cells. Stem Cell Reports. 2017 Feb 22. PMID: 28238796.
      View in: PubMed
    2. Cho GJ, Wang F, Garcia SM, Viner J, Hoffman WY, McDermott MW, Pomerantz J. Recalcitrant Invasive Skin Cancer of the Scalp: Combined Extirpation and Microsurgical Reconstruction Without Cranioplasty. J Craniofac Surg. 2016 Dec 30. PMID: 28045814.
      View in: PubMed
    3. Hesse RG, Kouklis GK, Ahituv N, Pomerantz J. The human ARF tumor suppressor senses blastema activity and suppresses epimorphic tissue regeneration. Elife. 2015; 4. PMID: 26575287; PMCID: PMC4657621.
    4. Xu X, Wilschut KJ, Kouklis G, Tian H, Hesse R, Garland C, Sbitany H, Hansen S, Seth R, Knott PD, Hoffman WY, Pomerantz J. Human Satellite Cell Transplantation and Regeneration from Diverse Skeletal Muscles. Stem Cell Reports. 2015 Sep 8; 5(3):419-34. PMID: 26352798; PMCID: PMC4618654.
    5. Balkin DM, Chen I, Oberoi S, Pomerantz J. Bilateral Coronoidectomy by Craniofacial Approach for Hecht Syndrome-Related Trismus. J Craniofac Surg. 2015 Sep; 26(6):1954-6. PMID: 26335328.
      View in: PubMed
    6. Tamaki S, Nye C, Slorach E, Scharp D, Blau HM, Whiteley PE, Pomerantz J. Simultaneous silencing of multiple RB and p53 pathway members induces cell cycle reentry in intact human pancreatic islets. BMC Biotechnol. 2014; 14:86. PMID: 25305068; PMCID: PMC4287515.
    7. Pomerantz J, Blau HM. Tumor suppressors: enhancers or suppressors of regeneration? Development. 2013 Jun; 140(12):2502-12. PMID: 23715544; PMCID: PMC3666379.
    8. Garland CB, Pomerantz J. Regenerative strategies for craniofacial disorders. Front Physiol. 2012; 3:453. PMID: 23248598; PMCID: PMC3521957.
    9. Blau HM, Pomerantz J. Re"evolutionary" regenerative medicine. JAMA. 2011 Jan 5; 305(1):87-8. PMID: 21177496; PMCID: PMC3105469.
    10. Sacco A, Mourkioti F, Tran R, Choi J, Llewellyn M, Kraft P, Shkreli M, Delp S, Pomerantz J, Artandi SE, Blau HM. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell. 2010 Dec 23; 143(7):1059-71. PMID: 21145579; PMCID: PMC3025608.
    11. Pajcini KV, Corbel SY, Sage J, Pomerantz J, Blau HM. Transient inactivation of Rb and ARF yields regenerative cells from postmitotic mammalian muscle. Cell Stem Cell. 2010 Aug 6; 7(2):198-213. PMID: 20682446; PMCID: PMC2919350.
    12. Pomerantz J, Mukherjee S, Palermo AT, Blau HM. Reprogramming to a muscle fate by fusion recapitulates differentiation. J Cell Sci. 2009 Apr 1; 122(Pt 7):1045-53. PMID: 19295131; PMCID: PMC2720934.
    13. Palermo A, Doyonnas R, Bhutani N, Pomerantz J, Alkan O, Blau HM. Nuclear reprogramming in heterokaryons is rapid, extensive, and bidirectional. FASEB J. 2009 May; 23(5):1431-40. PMID: 19141533; PMCID: PMC2669427.
    14. Pajcini KV, Pomerantz J, Alkan O, Doyonnas R, Blau HM. Myoblasts and macrophages share molecular components that contribute to cell-cell fusion. J Cell Biol. 2008 Mar 10; 180(5):1005-19. PMID: 18332221; PMCID: PMC2265408.
    15. Gruber RP, Weintraub J, Pomerantz J. Suture techniques for the nasal tip. Aesthet Surg J. 2008 Jan-Feb; 28(1):92-100. PMID: 19083512.
      View in: PubMed
    16. Wan DC, Pomerantz J, Brunet LJ, Kim JB, Chou YF, Wu BM, Harland R, Blau HM, Longaker MT. Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation. J Biol Chem. 2007 Sep 7; 282(36):26450-9. PMID: 17609215.
      View in: PubMed
    17. Zhang F, Pomerantz J, Sen G, Palermo AT, Blau HM. Active tissue-specific DNA demethylation conferred by somatic cell nuclei in stable heterokaryons. Proc Natl Acad Sci U S A. 2007 Mar 13; 104(11):4395-400. PMID: 17360535; PMCID: PMC1838613.
    18. Wehrman TS, Raab WJ, Casipit CL, Doyonnas R, Pomerantz J, Blau HM. A system for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactions. Proc Natl Acad Sci U S A. 2006 Dec 12; 103(50):19063-8. PMID: 17148612; PMCID: PMC1748177.
    19. Palermo AT, Labarge MA, Doyonnas R, Pomerantz J, Blau HM. Bone marrow contribution to skeletal muscle: a physiological response to stress. Dev Biol. 2005 Mar 15; 279(2):336-44. PMID: 15733662.
      View in: PubMed
    20. Pomerantz J, Blau HM. Nuclear reprogramming: a key to stem cell function in regenerative medicine. Nat Cell Biol. 2004 Sep; 6(9):810-6. PMID: 15340448.
      View in: PubMed
    21. Orlow I, Rabbani F, Chin L, Pomerantz J, Ligeois N, Dudas M, Depinho R, Cordón-Cardó C. Involvement of the Ink4a gene (p16 and p19arf) in murine tumorigenesis. Int J Oncol. 1999 Jul; 15(1):17-24. PMID: 10375589.
      View in: PubMed
    22. Chin L, Pomerantz J, DePinho RA. The INK4a/ARF tumor suppressor: one gene--two products--two pathways. Trends Biochem Sci. 1998 Aug; 23(8):291-6. PMID: 9757829.
      View in: PubMed
    23. Pomerantz J, Schreiber-Agus N, Liégeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C, DePinho RA. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell. 1998 Mar 20; 92(6):713-23. PMID: 9529248.
      View in: PubMed
    24. Chin L, Pomerantz J, Polsky D, Jacobson M, Cohen C, Cordon-Cardo C, Horner JW, DePinho RA. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev. 1997 Nov 1; 11(21):2822-34. PMID: 9353252; PMCID: PMC316663.
    25. Feldherr CM, Pomerantz J. Mechanism for the selection of nuclear polypeptides in Xenopus oocytes. J Cell Biol. 1978 Jul; 78(1):168-75. PMID: 566759; PMCID: PMC2110164.
    Jason's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP